Devices for Screening and Monitoring of Tumors Based on Chemoresistive Sensors

In this work two devices are presented, named SCENT A1 (A1) and SCENT B1 (B1), composed of chemoresistive sensors. Such devices are capable of discriminating the different compositions of gas mixtures emitted by stools, for colorectal cancer screening (A1), and by blood, for tumors monitoring (B1), according to defined sampling protocols. Results have been acquired by a LabView® software and statistically treated (e.g. quadratic discriminant analysis, QDA) and show to be encouraging with an error of 5% for SCENT A1. Preliminary results of SCENT B1 proved to be promising. Further studies will be carried out for clinically validating the two devices.